Trial site
Warsaw
- 6running trials
- 14closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Multiple sclerosis4 trials
- Familial hypercholesterolaemia2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Atopic dermatitis (eczema)1 trial
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- Lupus (SLE)1 trial
- Osteoarthritis1 trial
- and 2 more
- Phase
- Phase 311 trials
- Phase 27 trials
- Phase 11 trial
- Status
- Completed11 trials
- Active, not recruiting5 trials
- Terminated3 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Terminated
Completed
Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Completed
Completed
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Completed
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Terminated
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026